CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 
 

SCPH's Net Income Growth by Quarter and Year

Scpharmaceuticals Inc 's Net Income results by quarter and year




SCPH Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -7.32 -7.78 -10.82
III Quarter September -10.16 -6.55 -9.04 -6.21
II Quarter June -9.70 -7.06 -8.30 -7.26
I Quarter March -7.73 -7.10 -7.09 -8.72
FY   -27.59 -28.03 -32.21 -33.01



SCPH Net Income third quarter 2022 Y/Y Growth Comment
Scpharmaceuticals Inc in the third quarter 2022 recorded net loss of $ -10.16 millions.

According to the results reported in the third quarter 2022, Scpharmaceuticals Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Scpharmaceuticals Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2022.




SCPH Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scpharmaceuticals Inc 's third quarter 2022 Net Income $ -10.16 millions SCPH's Income Statement
Scpharmaceuticals Inc 's third quarter 2021 Net Income $ -6.55 millions Quarterly SCPH's Income Statement
New: More SCPH's historic Net Income Growth >>


SCPH Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scpharmaceuticals Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q Net Income Comment
Current net loss of -10.16 millions by Scpharmaceuticals Inc come out even less good if you take a look at net loss -9.70 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential Net Income growth. While Scpharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q Net Income Comment
Recent net loss of -10.16 millions by Scpharmaceuticals Inc come out even less good if you take a look at net loss -9.70 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential Net Income growth. While Scpharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Scpharmaceuticals Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ -34.91 $ -31.30 $ -28.66 $ -28.03 $ -28.50
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months net loss of $ -35 millions in the Sep 30 2022 period.
The business is worsening as the cumulative net loss is inflating from $ -31.3 millions in TTM ending quarter Jun 30 2022 and $ -9.7 millions from the TTM period ending Sep 30 2021.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months net loss of $ -35 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative net loss is getting bigger from $ -31.3 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -9.7 millions for the twelve months ending in the quarter a year ago Anika Tambe  mentioned.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
SCPH's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for SCPH's Competitors
Net Income Growth for Scpharmaceuticals Inc 's Suppliers
Net Income Growth for SCPH's Customers

You may also want to know
SCPH's Annual Growth Rates SCPH's Profitability Ratios SCPH's Asset Turnover Ratio SCPH's Dividend Growth
SCPH's Roe SCPH's Valuation Ratios SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio
SCPH's Roa SCPH's Inventory Turnover Ratio SCPH's Growth Rates SCPH's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Abiomed Inc 86.35%$ 86.352 millions
Stryker Corp86.30%$ 86.301 millions
Universal Security Instruments Inc86.27%$ 86.267 millions
American Shared Hospital Services83.33%$ 83.333 millions
Carlisle Companies Incorporated79.24%$ 79.240 millions
Vir Biotechnology Inc 58.76%$ 58.757 millions
United Therapeutics Corporation47.08%$ 47.081 millions
Dexcom Inc 42.74%$ 42.736 millions
Medpace Holdings Inc 35.93%$ 35.931 millions
Zimmer Biomet Holdings Inc 33.20%$ 33.196 millions
Iradimed Corporation33.03%$ 33.026 millions
Eli Lilly And Company30.77%$ 30.772 millions
Bio techne Corp30.09%$ 30.085 millions
Merit Medical Systems Inc27.62%$ 27.618 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NPHC's Profile

Stock Price

NPHC's Financials

Business Description

Fundamentals

Charts & Quotes

NPHC's News

Suppliers

NPHC's Competitors

Customers & Markets

Economic Indicators

NPHC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071